LIST OF BINDING INTERFACES for query 'DIPEPTIDYL PEPTIDASE 4' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
2rgu	356	Linagliptin (DB08882)	Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.	DIPEPTIDYL PEPTIDASE 4 (Homo sapiens)	DPPIV_N Peptidase_S9	2RGU_A_356A901	Details
3g0b	T22	Alogliptin (DB06203)	Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to treat hyperglycemia in patients with type 2 diabetes mellitus.	DIPEPTIDYL PEPTIDASE 4 (Homo sapiens)	DPPIV_N Peptidase_S9	3G0B_A_T22A800	Details
4ffw	715	Sitagliptin (DB01261)	Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used for the management of type 2 diabetes mellitus.	DIPEPTIDYL PEPTIDASE 4 (Rattus norvegicus; mus musculus)	DPPIV_N Peptidase_S9	4FFW_A_715A801	Details
6b1e	LF7	Vildagliptin (DB04876)	Vildagliptin is a once-daily dipeptidyl peptidase 4 (DPP-4) inhibitor used in the management of type 2 diabetes mellitus.	DIPEPTIDYL PEPTIDASE 4 (Homo sapiens)	DPPIV_N Peptidase_S9	6B1E_A_LF7A801	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["2rgu","356","Linagliptin (DB08882)","Homo sapiens","DIPEPTIDYL PEPTIDASE 4","DPPIV_N;Peptidase_S9"],["3g0b","T22","Alogliptin (DB06203)","Homo sapiens","DIPEPTIDYL PEPTIDASE 4","DPPIV_N;Peptidase_S9"],["4ffw","715","Sitagliptin (DB01261)","Rattus norvegicus;mus musculus","DIPEPTIDYL PEPTIDASE 4","DPPIV_N;Peptidase_S9"],["6b1e","LF7","Vildagliptin (DB04876)","Homo sapiens","DIPEPTIDYL PEPTIDASE 4","DPPIV_N;Peptidase_S9"]]